Listen guys, CIM is a cheap stock to buy...for only $3.20/share, great balance sheet overall. So if you have 1,000 shares, expect to get $360 in cash every year. You can't get that anywhere else, not savings, not money market, and definitely not bonds or cds. My point is, if you have extra cash to invest, invest in CIM and get a mediocre return that should satisfy your investment needs.
Long-term investor here that is very appreciative of the cash dividends I get every year and I only have 10,000 shares.
Funnimone, I think you're looking at yourself in the mirror way too much that's why! I know your parents are disappointed, but Citibank only reverse split when it was at $5! But before that, it was at $1.25 then because of TARP, the stock went to $5/share. As a stock investor, no one cares how the stock increased or decreased, as long as it does! So those who bought at a low price made it to Mazatlan!
If Navidea can report that the sales coming from Lymphoseek is worldwide, and give it by %age, then rest assure the stock will go up. Until then, no amount of news (unless buyout) will move this stock. We all know this is manipulated...company as strong as NAVB should be at least $5/share!
We all know that this stock is manipulated. The only way this will go up is through major revenue streams. The questions for management when the earnings call happen in March is what is happening to the Euro penetration and other nations? China, if ever, should be penetrated by our Hong Kong partner.
Hope this coming earnings call is great news on U.S. revenues! We did up the price so that should help...